Cerebral palsy: Prenatal risk factors;Parálisis cerebral: Factores de riesgo prenatales

Revista de Neurologia

Volumn 37, Issue 3, 2003, Pages 275-280

  Pascual, Juan M ^a,b   Koenigsberger, M R ^a  

^a Children's Hospital of New York ^*  (United States)

^b NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Cerebral palsy; Congenital; Fetal; Intrauterine; Leukomalacia; Paraplegia; Spasticity

Indexed keywords

COCAINE; HYDANTOIN; METHYLMERCURY;

CEREBRAL PALSY; CONFERENCE PAPER; ENCEPHALOMALACIA; HAPPY PUPPET SYNDROME; HUMAN; INTRAUTERINE INFECTION; LESCH NYHAN SYNDROME; MATERNAL DIABETES MELLITUS; MUSCULAR DYSTROPHY; PERINATAL ASPHYXIA; PRENATAL CARE; PRENATAL DRUG EXPOSURE; RETT SYNDROME; RISK ASSESSMENT; RISK FACTOR;

EID: 0141955236     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3703.2003133     Document Type: Conference Paper

References (54)

1. Winter S, Autry A, Boyle C, Yeargin-Allsopp M. Trends in the prevalence of cerebral palsy in a population-based study. Pediatrics 2002; 110: 1220-5.
2. Nelson KB. The epidemiology of cerebral palsy in term infants. Ment Retard Dev Disabil Res Rev 2002; 8: 146-50.
3. Volpe JJ. Brain injury in the premature infant: overview of clinical aspects, neuropathology, and pathogenesis. Semin Pediatr Neurol 1998; 5: 135-51.
4. Vannucci RC. Experimental biology of cerebral hypoxia-ischemia: relation to perinatal brain damage. Pediatr Res 1990; 27: 317-26.
5. Nelson KB, Leviton A. How much of neonatal encephalopathy is due to birth asphyxia? Am J Dis Child 1991; 145: 1325-31.
6. Volpe JJ. Brain injury in the premature infant-current concepts of pathogenesis and prevention. Biol Neonate 1992; 62: 231-42.
7. Pryds O. Control of cerebral circulation in the high-risk neonate. Ann Neurol 1991; 30: 321-9.
8. Choi DW, Monyer H, Giffard RG, Goldberg MP, Christine CW. Acute brain injury, NMDA receptors, and hydrogen ions: observations in cortical cell cultures. Adv Exp Med Biol 1990; 268: 501-4.
9. Siesjo BK, Bengtsson F. Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis. J Cereb Blood Flow Metab 1989; 9: 127-40.
10. Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 2001; 50: 553-62.
11. Siesjo BK, Plum F. Cerebral energy metabolism in normoxia and in hypoxia. Acta Anaesthesiol Scand Suppl 1971; 45: 81-101.
12. Forsyth R, Fray A, Boutelle M, Fillenz M, Middleditch C, Burchell A. A role for astrocytes in glucose delivery to neurons? Dev Neurosci 1996; 18: 360-70.
13. Stys PK. Anoxic and ischemic injury of myelinated axons in CNS white matter: from mechanistic concepts to therapeutics. J Cereb Blood Flow Metab 1998; 18: 2-25.
14. Meldrum BS, Evans MC, Swan JH, Simon RP. Protection against hypoxic/ischaemic brain damage with excitatory amino acid antagonists. Med Biol 1987; 65: 153-7.
15. Gunn AJ, Gluckman PD, Gunn TR. Selective head cooling in newborn infants after perinatal asphyxia: a safety study. Pediatrics 1998; 102: 885-92.
16. Levene MI, Gibson NA, Fenton AC, Papathoma E, Barnett D. The use of a calcium-channel blocker, nicardipine, for severely asphyxiated newborn infants. Dev Med Child Neurol 1990; 32: 567-74.
17. Gunn AJ, Gunn TR, de Haan HH, Williams CE, Gluckman PD. Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs. J Clin Invest 1997; 99: 248-56.
18. Gupta R, Appleton RE. Cerebral palsy: not always what it seems. Arch Dis Child 2001; 85: 356-60.
19. Clayton-Smith J, Laan L. Angelman syndrome: a review of the clinical and genetic aspects. J Med Genet 2003; 40: 87-95.
20. Shahbazian MD, Zoghbi HY. Rett syndrome and MeCP2: linking epigenetics and neuronal function. Am J Hum Genet 2002; 71: 1259-72.
21. Dubowitz V. Congenital muscular dystrophy: an expanding clinical syndrome. Ann Neurol 2000; 47: 143-4.
22. Fink JK. Hereditary spastic paraplegia. Neurol Clin 2002; 20: 711-26.
23. Zeviani M, Bonilla E, DeVivo DC, DiMauro S. Mitochondrial diseases. Neurol Clin 1989; 7: 123-56.
24. Robinson BH, MacKay N, Chun K, Ling M. Disorders of pyruvate carboxylase and the pyruvate dehydrogenase complex. J Inherit Metab Dis 1996; 19: 452-62.
25. Segawa M, Nishiyama N, Nomura Y. DOPA-responsive dystonic parkinsonism-pathophysiologic considerations. Adv Neurol 1999; 80: 389-400.
26. Opitz JM, Gilbert-Barness E, Ackerman J, Lowichik A. Cholesterol and development: the RSH ('Smith-Lemli-Opitz') syndrome and related conditions. Pediatr Pathol Mol Med 2002; 21: 153-81.
27. Hoffmann GF, Zschocke J. Glutaric aciduria type I: from clinical, biochemical and molecular diversity to successful therapy. J Inherit Metab Dis 1999; 22: 381-91.
28. Nyhan WL. The recognition of Lesch-Nyhan syndrome as an inborn error of purine metabolism. J Inherit Metab Dis 1997; 20: 171-8.
29. Boulloche J, Aicardi J. Pelizaeus-Merzbacher disease: clinical and nosological study. J Child Neurol 1986; 1: 233-9.
30. Yool DA, Edgar JM, Montague P, Malcolm S. The proteolipid protein gene and myelin disorders in man and animal models. Hum Mol Genet 2000; 9: 987-92.
31. Iyer R, Jenkinson CP, Vockley JG, Kem RM, Grody WW, Cederbaum S. The human arginases and arginase deficiency. J Inherit Metab Dis 1998; 21 (Suppl 1): S86-100.
32. Kadhim H, Tabarki B, Prez CD, Sebire G. Cytokine immunoreactivity in cortical and subcortical neurons in periventricular leukomalacia: are cytokines implicated in neuronal dysfunction in cerebral palsy? Acta Neuropathol (Berl) 2003; 105: 209-16.
33. Leviton A. Preterm birth and cerebral palsy: is tumor necrosis factor the missing link? Dev Med Child Neurol 1993; 35: 553-8.
34. Sánchez PJ. Perinatal infections and brain injury: current treatment options. Clin Perinatol 2002; 29: 799-826.
35. Eklind S, Mallard C, Leverin AL, Gilland E, Blomgren K, Mattsby-Baltzer I, et al. Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury. Eur J Neurosci 2001; 13: 1101-6.
36. Ghezzi F, Gómez R, Romero R, Yoon BH, Edwin SS, David C, et al. Elevated interleukin-8 concentrations in amniotic fluid of mothers whose neonates subsequently develop bronchopulmonary dysplasia. Eur J Obstet Gynecol Reprod Biol 1998; 78: 5-10.
37. Wu YW. Systematic review of chorioamnionitis and cerebral palsy. Ment Retard Dev Disabil Res Rev 2002; 8: 25-9.
38. Wu YW, Colford JM, Jr. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 2000; 284: 1417-24.
39. Nissenkorn A, Michelson M, Ben-Zeev B, Lerman-Sagie T. Inborn errors of metabolism: a cause of abnormal brain development. Neurology 2001; 56: 1265-72.
40. Ross ME, Walsh CA. Human brain malformations and their lessons for neuronal migration. Annu Rev Neurosci 2001; 24: 1041-70.
41. Tassi L, Colombo N, Garbelli R, Francione S, Lo Russo G, Mai R, et al. Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain 2002; 125: 1719-32.
42. Bruner JP, Tulipan N, Paschall RL, Boehm FH, Walsh WF, Silva SR, et al. Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus. JAMA 1999; 282: 1819-25.
43. DeVore GR. The genetic sonogram: its use in the detection of chromosomal abnormalities in fetuses of women of advanced maternal age. Prenat Diagn 2001; 21: 40-5.
44. Burke CJ, Tannenberg AE. Prenatal brain damage and placental infarction -an autopsy study. Dev Med Child Neurol 1995; 37: 555-62.
45. Scher MS, Wiznitzer M, Bangert BA. Cerebral infarctions in the fetus and neonate: maternal-placental-fetal considerations. Clin Perinatol 2002; 29: 693-724, vi-vii.
46. Golomb MR, MacGregor DL, Domi T, Armstrong DC, McCrindle BW, Mayank S, et al. Presumed pre- or perinatal arterial ischemic stroke: risk factors and outcomes. Ann Neurol 2001; 50: 163-8.
47. Harada M. Minamata disease: methylmercury poisoning in Japan caused by environmental pollution. Crit Rev Toxicol 1995; 25: 1-24.
48. Mendola P, Selevan SG, Gutter S, Rice D. Environmental factors associated with a spectrum of neurodevelopmental deficits. Ment Retard Dev Disabil Res Rev 2002; 8: 188-97.
49. Arpino C, Brescianini S, Robert E, Castilla EE, Cocchi G, Cornel MC, et al. Teratogenic effects of antiepileptic drugs: use of an International Database on Malformations and Drug Exposure (MADRE). Epilepsia 2000; 41: 1436-43.
50. Chiriboga CA, Vibbert M, Malouf R, Suárez MS, Abrams EJ, Heagarty MC, et al. Neurological correlates of fetal cocaine exposure: transient hypertonia of infancy and early childhood. Pediatrics 1995; 96: 1070-7.
51. Vaarasmaki MS, Hartikainen A, Anttila M, Pramila S, Koivisto M. Factors predicting peri- and neonatal outcome in diabetic pregnancy. Early Hum Dev 2000; 59: 61-70.
52. Blickstein I. Cerebral palsy in multifoetal pregnancies. Dev Med Child Neurol 2002; 44: 352-5.
53. Malone FD, Craigo SD, Chelmow D, D'Alton ME. Outcome of twin gestations complicated by a single anomalous fetus. Obstet Gynecol 1996; 88: 1-5.
54. University of Washington-National Institutes of Health. GeneTests: Medical Genetics Information Resource (database online): www. geneclinics.org. Fecha última consulta: 05.06.2003.